Michelle Yanez

Director, Inhibitor Therapeutics, Inc.

Companies

Inhibitor Therapeutics, Inc.Board member Dec 22, 2022 to now¹
MIRA PHARMACEUTICALS, INC.Chief financial officer Aug 2, 2023 to Dec 10, 2024²
Telomir Pharmaceuticals, Inc.Chief financial officer Aug 29, 2024 to Sep 4, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibitor Therapeutics, Inc. INTI1,221,271 shares⁴$134.3K at $0.11May 4, 2026
Telomir Pharmaceuticals, Inc. TELO24,391 shares⁵$25.4K at $1.04Aug 29, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 4, 2026Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁴
Apr 1, 2025Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁶
Dec 2, 2024Gift 250,000 shares of Inhibitor Therapeutics, Inc.⁷
Apr 1, 2024Granted 50,000 shares of Inhibitor Therapeutics, Inc.⁸
May 5, 2023Other 796,271 shares of Inhibitor Therapeutics, Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibitor Therapeutics, Inc., Board member
2
SEC EDGARMIRA PHARMACEUTICALS, INC., Chief financial officer
3
SEC EDGARTelomir Pharmaceuticals, Inc., Chief financial officer
4
SEC EDGARInhibitor Therapeutics, Inc. shares after the filing of May 4, 2026
5
SEC EDGARTelomir Pharmaceuticals, Inc. shares after the filing of Aug 29, 2024
6
SEC EDGARForm 4 filed Apr 7, 2025
7
SEC EDGARForm 5 filed Feb 19, 2025
8
SEC EDGARForm 4 filed May 16, 2024
9
SEC EDGARForm 4 filed May 17, 2023